Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
MODIFICATION TO INCREASE 596A10007 BY $47,750.00. LINE ITEM #2 ADD 55 BOXES (NEW TOTAL 175 BOXES), $860.00 PER BOX & LINE ITEM #3 ADD 3 KITS (NEW TOTAL 18 KITS), $150.00 PER KIT. is a federal award for 249-Network Contract Office 9 (36C249) held by Roche Diagnostics Corp. Estimated value $139K ($48K obligated). Current period of performance ends Sep 18, 2022 (potential Sep 18, 2026). Place of performance: INDIANAPOLIS IN.
MODIFICATION TO INCREASE 596A10007 BY $47,750.00. LINE ITEM #2 ADD 55 BOXES (NEW TOTAL 175 BOXES), $860.00 PER BOX & LINE ITEM #3 ADD 3 KITS (NEW TOTAL 18 KITS), $150.00 PER KIT.
Recompete timing
PublicCurrent PoP ended Sep 18, 2022 (1433 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24921N0286?
36C24921N0286 (Modification to increase 596a10007 BY $47) is a 249-Network Contract Office 9 (36C249) award with a potential value of $139K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C249-21-N-0286?
36C249-21-N-0286 is the dashed form of PIID 36C24921N0286 (Modification to increase 596a10007 BY $47), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24921N0286?
249-Network Contract Office 9 (36C249) awarded 36C24921N0286 to Roche Diagnostics Corp (potential $139K).
Who is the incumbent on 36C24921N0286?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 18, 2022.
When does Roche Diagnostics Corp’s 36C24921N0286 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 18, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.